Skip to main content
. 2004 Aug;2(3):181–187. doi: 10.3121/cmr.2.3.181

Table 2.

Characteristics of the three groups of patients at inclusion.*

Characteristic Community-acquired pneumonia (n=38) Ventilator-associated pneumonia (n=46) No pneumonia (n=64) P value
Duration of mechanical ventilation before study entry [days] 0.4 ± 0.2 6.4 ± 8.5 2.1 ± 4.8 <0.001
Previous antimicrobial therapy [n (%)] 33 (87) 19 (41) 30 (47) <0.001
Shock [n (%)] 18 (47) 19 (41) 30 (47) 0.49
Body temperature [°C] 37.9 ± 2.0 38.1 ± 0.9 37.7 ± 1.1 0.82
Leukocyte count [g/l] 12.8 ± 7.9 13.4 ± 8.5 12.5 ± 5.8 0.99
PaO2/FiO2 [mmHg] 181 ± 80 203 ± 67 206 ± 91 0.51
PCT [ng/ml] 3.7 ± 1.9 2.6 ± 0.8 2.5 ± 1.2 0.58
CRP [mg/l] 197 ± 128 184 ± 108 141 ± 110 0.34
BAL fluid TNF-α [pg/ml] 298.2 ± 47.7 290.5 ± 39.7 147.2 ± 25.1 <0.001
BAL fluid TNF-1β [pg/ml] 92.5 ± 22.5 95.1 ± 29.4 41.5 ± 12.5 <0.001
BAL fluid sTREM-1 [pg/ml] 23.2 ± 2.8 33.6 ± 5.1 1.8 ± 0.9 <0.001

* Values are expressed as the mean ± Standard Deviation unless otherwise indicated.

P values are comparisons between community-acquired pneumonia, ventilator-associated pneumonia, and no pneumonia groups. Mann Whitney U test for numerical data and Pearson χ2 test for categorical data.

BAL, bronchoalveolar lavage; CRP, C-reactive protein; PaO2/FiO2, ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen; PCT, procalcitonin; sTREM-1, soluble triggering receptor expressed on myeloid cells-1; TNF, tumor necrosis factor.